Safety for Biosimilars: Strategic Pharmacovigilance Solutions, Upcoming Webinar Hosted by Xtalks

In this free webinar, gain insight into the evolving global regulatory landscape for biosimilar approval, labelling and pharmacovigilance requirements. Attendees will learn how to design scalable pharmacovigilance strategies explicitly tailored for biosimilars throughout the product lifecycle. The featured speakers will explore how advanced technologies and automation can enhance biosimilar safety monitoring and streamline surveillance. Attendees will discover practical approaches to support physician, provider and patient confidence in biosimilars through education and engagement.

TORONTO, Oct. 2, 2025 /PRNewswire/ -- The rapidly expanding landscape of biosimilars presents significant opportunities for increasing patient access to cost-effective alternatives to brand-name biologics, but this also creates unique challenges. Unlike small molecule generics, biosimilars are large, complex molecules with inherent batch-to-batch variability that requires stringent pharmacovigilance across the product lifecycle. To navigate the complexities of biosimilar development and post-market surveillance, it is critical to understand both the evolving regulatory frameworks and the reference products for the biosimilar of interest.

In this webinar, the featured speakers will examine the critical aspects of bringing biosimilars to market and ensuring their ongoing safety and efficacy. They will also explore how pharmaceutical companies can develop effective and scalable pharmacovigilance systems that address the distinct requirements of biosimilar products while maintaining cost-efficiency. Practical solutions for overcoming the most pressing challenges in biosimilar safety management will also be highlighted.

Topics will include:

• Developing pharmacovigilance strategies tailored to biosimilars
• Leveraging advanced technologies and automation to streamline safety surveillance
• Understanding evolving regulations for biosimilar approval and pharmacovigilance
• Building educational frameworks to support provider and patient adoption

Register for this webinar to learn how strategic pharmacovigilance can improve biosimilar manufacturing and support product adoption.

Join experts from PrimeVigilance, Ivana Lisec, VP, Project Management/Business Unit Leader & EU QPPV; and Sara Lipovac, Senior Case Processing Manager, for the live webinar on Friday, October 17, 2025, at 10am EDT (4pm CEST/EU-Central).

For more information or to register for this event, visit Safety for Biosimilars: Strategic Pharmacovigilance Solutions.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks, visit www.xtalks.com
For information about hosting a webinar, visit www.xtalks.com/why-host-a-webinar/

Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: [email protected]

View original content to download multimedia:https://www.prnewswire.com/news-releases/safety-for-biosimilars-strategic-pharmacovigilance-solutions-upcoming-webinar-hosted-by-xtalks-302573364.html

SOURCE Xtalks